• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$33.09 $0.10 (0.30%)

REAL-TIME: Last trade at

Bristol-Myers Squibb Co.

NYSE:BMY

Jump to this page for:

Related Resources

Amylin Said to Get Bids From Sanofi, Merck in First Round of Sale Offers

5/26/2012 by Bloomberg.com

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3

5/25/2012 by Seeking Alpha

Senate passes FDA funding bill, Reuters reports

5/25/2012 by Theflyonthewall.com

Bristol-Myers Squibb to Take Part in Sanford Bernstein’s 28th Annual Strategic Decisions Conference

5/24/2012 by StockWatch

Bristol-Myers Squibb to Take Part in Sanford Bernstein’s 28th Annual Strategic Decisions Conference

5/24/2012 by Business Wire

Plan to Speed Up FDA Reviews for New Drugs and Medical Devices Moved to Senate

5/24/2012 by Marketwire

J&J's Xarelto likely delayed 3-12 months, not dead, says Leerink

5/24/2012 by Theflyonthewall.com

Celldex Targeted Drug Shrinks Breast Cancer

5/23/2012 by TheStreet.com

Pharma's Rare Disease Strategy

5/23/2012 by CNBC Video

Diabetes Initiative Expands to China, India

5/23/2012 by Drug Discovery & Development

Global pharma

5/22/2012 by FT.com

The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories

5/22/2012 by PR Newswire

The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories - Press Releases

5/22/2012 by Zacks Investment Research

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan

5/21/2012 by PR Newswire

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan - Press Releases

5/21/2012 by Zacks Investment Research

Generic Versions of Plavix Get FDA Approval

5/18/2012 by InvestorPlace

Bristol Myers Squibb Started as “Outperform” at BMO Capital (BMY)

5/18/2012 by Dividend.com

Analysts' Actions: AZO, BMY, LLY, MS

5/18/2012 by TheStreet.com

BMO Capital Starts Bristol-Myers Squibb Co. (BMY) at Outperform

5/18/2012 by StreetInsider.com

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

5/18/2012 by 24/7 Wall Street

Bristol-Myers initiated with an Outperform at BMO Capital

5/18/2012 by Theflyonthewall.com

Dr. Reddy's Labs announces the launch of Clopidogrel tablets, USP

5/18/2012 by Theflyonthewall.com

Lilly, Jaguar Land Rover, Viacom: Intellectual Property

5/18/2012 by Bloomberg.com

Gilead Sciences’ HIV Drugs Clear a Hurdle

5/17/2012 by InvestorPlace

BMS Funding Chinese Research

5/17/2012 by Drug Discovery & Development

Bristol-Myers Squibb Company Exec Writes Book for Punishment

5/17/2012 by BioSpace

Bristol Myers Squibb Anticipates Significant Decline In Sales In The US For Clopidogrel

5/17/2012 by PRWeb

New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

5/17/2012 by PharmiWeb.com - UK

A Big Trade on Big Pharma

5/17/2012 by InvestorPlace

New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

5/16/2012 by Business Wire

Clot-Fighting Drug Plavix Set to Lose Patent Protection

5/16/2012 by International Herald Tribune - France

What's Next For Pharma?

5/16/2012 by CNBC Video

Manufacturing Facility Cleared at BMY - Analyst Blog

5/16/2012 by Zacks Investment Research

Manufacturing Facility Cleared at BMY

5/16/2012 by Zacks Equity Research Analyst Blog

MYERS SQUIBB FOUNDATION ANNOUNCES $15 MILLION EXPANSION OF TOGETHER ON DIABETES® TO INDIA AND CHINA

5/16/2012 by PharmiWeb.com - UK

After Sentence to Write Sentences, Man Ends Legal Chapter

5/15/2012 by The Wall Street Journal

BMY Inks Deal with Chinese University

5/15/2012 by Zacks Equity Research Analyst Blog

BMY Inks Deal with Chinese University - Analyst Blog

5/15/2012 by Zacks Investment Research

U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility for Production of ORENCIA®

5/15/2012 by Pharmaceutical Online

Bristol-Myers says FDA clears Mass. plant

5/15/2012 by The Boston Globe - Boston MA
See More Articles...